BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32106364)

  • 1. SNRPB promotes cervical cancer progression through repressing p53 expression.
    Zhu L; Zhang X; Sun Z
    Biomed Pharmacother; 2020 May; 125():109948. PubMed ID: 32106364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MFAP5 suppression inhibits migration/invasion, regulates cell cycle and induces apoptosis via promoting ROS production in cervical cancer.
    Li Q; Zhang Y; Jiang Q
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):51-58. PubMed ID: 30454902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
    Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
    IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma.
    Zhan YT; Li L; Zeng TT; Zhou NN; Guan XY; Li Y
    Aging (Albany NY); 2020 Dec; 13(1):537-554. PubMed ID: 33289700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26.
    Liu N; Wu Z; Chen A; Wang Y; Cai D; Zheng J; Liu Y; Zhang L
    Cell Death Dis; 2019 Sep; 10(9):667. PubMed ID: 31511502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer.
    Liu N; Chen A; Feng N; Liu X; Zhang L
    Med Oncol; 2021 Apr; 38(5):57. PubMed ID: 33835288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
    Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
    J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway.
    Peng X; Zhang Y; Gao J; Cai C
    Exp Mol Pathol; 2020 Jun; 114():104368. PubMed ID: 31917289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
    Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
    Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer.
    Liao S; Xiao S; Chen H; Zhang M; Chen Z; Long Y; Gao L; He J; Ge Y; Yi W; Wu M; Li G; Zhou Y
    Int J Oncol; 2017 Nov; 51(5):1497-1507. PubMed ID: 29048616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZWINT promotes the proliferation, migration, and invasion of cervical cancer cells by regulating the p53/p21 signaling pathway.
    Ma Z; Cai Y; Tian C
    Chin J Physiol; 2023; 66(5):372-378. PubMed ID: 37929349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulatory effect of small nuclear ribonucleoprotein-associated protein B on proliferation and metastasis of liver cancer cells].
    Li YR; Guo D; Chen DF; Lu GF; Ren MD; He SX
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):63-68. PubMed ID: 35152671
    [No Abstract]   [Full Text] [Related]  

  • 17. Downregulation of long noncoding RNA DGCR5 contributes to the proliferation, migration, and invasion of cervical cancer by activating Wnt signaling pathway.
    Liu Y; Chang Y; Lu S; Xiang YY
    J Cell Physiol; 2019 Jul; 234(7):11662-11669. PubMed ID: 30552671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis.
    Wang X; Zhang H; Guo Z; Wang J; Lu C; Wang J; Jin R; Mo Z
    Aging (Albany NY); 2024 Jan; 16(1):348-366. PubMed ID: 38189879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
    Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome.
    Zhao P; Pang X; Jiang J; Wang L; Zhu X; Yin Y; Zhai Q; Xiang X; Feng F; Xu W
    Carcinogenesis; 2019 Jun; 40(4):592-599. PubMed ID: 30445600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.